Quoin Pharmaceuticals, Ltd. (QNRX) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $3.82M | +5.4% |
| 2024 | $3.62M | +50.9% |
| 2023 | $2.40M | -16.1% |
| 2022 | $2.86M | -61.8% |
| 2021 | $7.48M | +2210.7% |
| 2020 | $323.8K | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $3.82M | +5.4% |
| 2024 | $3.62M | +50.9% |
| 2023 | $2.40M | -16.1% |
| 2022 | $2.86M | -61.8% |
| 2021 | $7.48M | +2210.7% |
| 2020 | $323.8K | — |